Phase 2
Completed N=389
Effects of Magnesium on Individuals Undergoing Coronary Artery Bypass Graft Surgery
Coronary Disease · Heart Failure · Cardiovascular Disease · Neurologic Manifestations
Source: ClinicalTrials.gov NCT00041392 ↗
Enrolled (actual)
389
Serious AEs
17.7%
Results posted
Oct 2012
Primary outcomePrimary: Cognitive Function — 0.07; 0.12 Continuous cognitive change score
Summary
The purpose of this study is to examine the effects of supplemental magnesium on the neurocognitive function of individuals undergoing coronary artery bypass graft (CABG) surgery.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Cognitive Function |
0.07; 0.12 | — |
Eligibility Criteria
Inclusion Criteria
- Coronary heart disease
Exclusion Criteria
- Early dementia
- History of psychiatric illness
Data sourced from ClinicalTrials.gov (NCT00041392). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.